This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Kristine Peers
General Counsel at European Federation of Pharmaceutical Industries and Associations (EFPIA)

Profile

Kristine Peers is General Counsel at the European Federation of Pharmaceutical Industries and Associations (EFPIA) since September 2017.

Through its direct membership of 37 national associations, 38 leading pharmaceutical companies, and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy. Our vision is for a healthier future for Europe. A future based on prevention, innovation, access to new treatments and better outcomes for patients.


Kristine builds on a career combining legal expertise with public policy and government relations. She has worked in various legal and corporate affairs functions at Belgian, European and global level with GlaxoSmithKline and Pfizer. Prior to joining the pharmaceutical industry, Kristine practiced at

the Belgian Bar. She graduated in law from Leuven University, Belgium, and obtained a post graduate qualification in European Law at the European University Centre in Nancy, France, where she was also visiting lecturer teaching European regulations of medicinal products to health professionals. Throughout her career she had several legal, business and leadership trainings including at INSEAD and NYU Stern. She is co-founder of the Brussels Pharma Law Group, Board member of the AMR Industry Alliance and represents EFPIA at the Commission expert group ‘Antimicrobial resistance (AMR) One Health Network’.

Agenda Sessions

  • KEYNOTE PANEL: Industry Impact the EU Pharmaceutical Legislation Revision

    09:30

Speakers at this event